Vitamin D3, K2 & Magnesium Clinical analysis

Magnesium L-Threonate vs Glycinate: Evidence, Dose and Cost

L-threonate versus glycinate for sleep, cognition and intake: compare trials, elemental doses, tolerability, cost and combining forms.

Published
Last reviewed
Reading time
7 min
Sources cited
5
Two generic supplement presentations arranged for a magnesium comparison.
On this page

Magnesium L-threonate has more form-specific cognition research, while magnesium glycinate is commonly considered for general magnesium supplementation and sleep. Both have human sleep studies, and neither is established as a universal winner.

The most useful comparison considers the goal, the outcome measured, elemental magnesium, tolerability, capsule count and price. A claim about brain delivery cannot settle a sleep comparison, and a larger compound-weight number cannot settle an intake comparison.

L-threonate versus glycinate at a glance

Question L-threonate Glycinate/bisglycinate
Main formulation distinction Magnesium paired with L-threonate Magnesium paired with glycine; commercial formulations vary
Human cognition evidence Several small form-specific or formulation-specific trials No comparable basis for claiming superior cognition from the studies reviewed here
Sleep evidence Short 2024 and 2026 trials with selected positive and neutral outcomes A 2025 randomized trial found a small improvement in insomnia severity
Dose comparison Compound amounts often expressed in grams Compound amounts also differ from elemental magnesium
Practical buying issue Match the material and trial amount if using form-specific evidence Check elemental amount, buffered ingredients and the exact formulation
Proven direct clinical winner Not established Not established

Has a trial compared the two directly?

The main trials discussed here compare a form or formulation with placebo. They do not provide a randomized head-to-head test of matched L-threonate and glycinate products.

An indirect comparison can explain the evidence landscape. It cannot show that a larger effect in one trial proves superiority when participants, outcome scales, baseline symptoms and study duration differ.

This distinction is especially important for sleep. A wearable readiness score and an insomnia-severity questionnaire are not the same outcome.

Glycinate for sleep: the 2025 trial

A randomized bisglycinate study enrolled 155 adults with self-reported poor sleep. The active group received 250 mg elemental magnesium daily for four weeks.

Insomnia Severity Index scores fell by about 3.9 points in the active group and 2.3 in the placebo group. The approximately 1.6-point difference corresponds to a small reported effect size, Cohen's d = 0.2, with p = 0.049.

The result supports a modest short-term signal. It does not demonstrate a large or guaranteed improvement, and the study did not use objective sleep measurements to establish every aspect of sleep physiology. Exploratory findings about lower baseline intake need confirmation.

L-threonate for sleep: the 2024 and 2026 trials

The 2024 trial tested 1 g/day in 80 adults for 21 days. Selected wearable-derived sleep scores and daytime-function measures favored L-threonate.

The 2026 trial tested 2 g/day in 100 adults dissatisfied with sleep. Sleep-related impairment improved, while objective wearable sleep measures and several other subjective measures did not significantly differ.

These are useful findings, but they do not create a direct comparison with the bisglycinate study. The sleep review explains the outcome measures, study corrections and funding.

Research book and bedside lamp in a magnesium evidence still life.
Cognition and sleep are different outcomes with different evidence.

Cognition: why L-threonate attracts interest

An earlier MMFS-01 study reported better composite cognition in adults with cognitive complaints. The 2026 Magtein study also found selected cognitive improvements.

That gives L-threonate a more direct form-specific cognition literature. It does not establish dementia prevention, a physical reversal of brain age or superiority for every person with “brain fog.” Cognitive symptoms can have causes that deserve assessment.

Glycinate's role as a magnesium source does not automatically reproduce those findings. Equally, the existence of L-threonate trials does not establish that it is the best way for every person to address a simple dietary magnesium gap.

Does the glycine component matter?

Glycine is a distinct compound that has its own research. A glycinate supplement's glycine contribution depends on the amount and composition of the material. It should not be assumed to equal the gram-level glycine amounts used in separate studies.

“Contains glycine” is therefore a formulation fact, not proof that a magnesium capsule reproduces a stand-alone glycine intervention. The same evidence-matching rule applies to the threonate component of L-threonate.

Absorption and the blood-brain barrier

L-threonate's brain narrative partly comes from animal research. That is a reason for human study, but it does not quantify brain delivery from every retail capsule.

General magnesium bioavailability studies also should not be used to rank two forms that were not actually compared under the relevant conditions. “Highly absorbed” and “clinically better for sleep” are different claims.

For general intake, an accurate elemental declaration and a tolerable regimen can matter more than an unsupported percentage ranking.

Compound weight, elemental dose and buffered labels

The 2026 L-threonate trial used 2,000 mg compound to supply 145 mg elemental magnesium. A glycinate product's elemental amount depends on its specified material and serving size.

Some commercial glycinate products are buffered or blended with other salts. Read the complete ingredient declaration rather than assuming all of the magnesium comes from an identical chelate.

The dosage guide shows how to read serving sizes. The largest front-label number is not a fair basis for comparing magnesium intake.

Cost: compare the decision you are actually making

If a product costs $30 for 30 daily servings, its cost is $1 per day. If each serving provides 150 mg elemental magnesium, the illustrative cost per 100 mg is about $0.67.

A second product costing $20 for 60 daily servings costs about $0.33 per day. That does not automatically make it better: compare the actual elemental amount, formulation and purpose. These figures are hypothetical, not current market quotes.

For a form-specific cognition goal, matching the studied formulation matters. For an intake gap, cost per appropriate elemental amount may be more useful. Neither metric should override dose suitability.

Unbranded supplement containers beside a calculator and notebook.
Compare the actual formulation, elemental amount and daily serving.

Can you take both together?

There is no established universal need to combine them. If both are used in an appropriate plan, total the elemental magnesium from both and include other supplements or magnesium-containing medicines.

For example, 145 mg from one product plus 200 mg from another equals 345 mg supplemental magnesium. Different form names do not create separate allowances. Kidney function and medicine interactions still matter.

Which form fits which situation?

Situation Useful starting point
Main goal is matching form-specific cognition research Review L-threonate's exact formulation and trial amount
Main goal is addressing a dietary magnesium gap Compare elemental dose, tolerability and value across suitable products
Main goal is chronic insomnia Assess the sleep problem; neither form replaces appropriate insomnia care
Existing kidney disease or complex medicines Seek individual advice before selecting a form
Preference for a D3/MK-7/L-threonate combination Evaluate the fixed combination separately from stand-alone magnesium dosing

The L-threonate overview and safety guide support those decisions. The most defensible choice is the one whose actual formulation and evidence match the intended purpose.

Research and sources

Explore the D3, K2 and magnesium research data center for study summaries, population and formulation details, limitations and original publication links. Source links throughout this guide point to the relevant evidence or official guidance.

Frequently asked questions

Which form has better evidence for cognition?

L-threonate has more form-specific cognition research among the studies reviewed. This does not establish universal benefit, dementia prevention or superiority for every person.

Which form is better for sleep?

The trials do not establish a universal head-to-head winner. Glycinate has a small insomnia-severity signal, while L-threonate trials report selected positive and neutral sleep-related outcomes.

Does glycinate supply the same glycine dose as a separate sleep supplement?

Not necessarily. The contribution depends on the material and serving. A magnesium-glycinate label should not be assumed to reproduce a stand-alone glycine intervention.

Is buffered glycinate identical to every other glycinate product?

No. Some formulations blend or buffer with other magnesium salts. Read the full ingredient and elemental declaration.

Is more expensive threonate automatically better absorbed?

Price does not establish absorption or clinical superiority. Compare the evidence relevant to the actual formulation, dose and goal.

Can either replace chronic-insomnia treatment?

The short supplement studies do not establish that. Persistent sleep problems deserve assessment and treatment matched to the diagnosis.

Share this article

Send the research to someone who would find it useful.

Facebook X LinkedIn Reddit WhatsApp Email

Sources & article history

Sources (5)
  1. Julius Schuster, et al. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial Nature and science of sleep. 2025;17:2027-2040.
  2. Heather A Hausenblas, et al. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial Sleep medicine: X. 2024;8:100121.
  3. Adrian L Lopresti, et al. The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial Frontiers in nutrition. 2026;12:1729164.
  4. Guosong Liu, et al. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial Journal of Alzheimer's disease : JAD. 2016;49(4):971-90.
  5. Inna Slutsky, et al. Enhancement of learning and memory by elevating brain magnesium Neuron. 2010;65(2):165-77.